Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Apr;56(4):849-54.
doi: 10.1128/iai.56.4.849-854.1988.

Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity

Affiliations

Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity

J R Perfect et al. Infect Immun. 1988 Apr.

Abstract

The functional abilities of macrophages from cerebrospinal fluid (CSF) have so far been little studied. We examined the acquisition of activation characteristics by CSF macrophages during the course of experimental cryptococcal meningitis. CSF macrophages developed the ability for increased reactive oxidative intermediate (H2O2) production and tumor and fungal cytotoxicity. Despite having been activated, CSF macrophages could not inhibit the growth of Cryptococcus neoformans in vitro. Immunosuppression with cyclosporine, which eliminates the natural resistance of rabbits to cryptococcal meningitis, did not prevent or diminish H2O2 production by CSF macrophages but did reduce their tumoricidal activity. Activation of CSF macrophages appears to be an integral part of the central nervous system immune response to C. neoformans in this model, but alone is insufficient to eliminate C. neoformans from the central nervous system.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Acta Neuropathol. 1968 Jun 7;10(4):359-62 - PubMed
    1. J Neuropathol Exp Neurol. 1963 Oct;22:643-76 - PubMed
    1. Infect Immun. 1973 Feb;7(2):231-6 - PubMed
    1. J Clin Invest. 1975 Feb;55(2):338-46 - PubMed
    1. Infect Immun. 1976 Jul;14(1):6-10 - PubMed

Publication types

Substances